FDA Permits Modified Risk Claims for ZYN Nicotine Pouches

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-30
Category: health
Source: FDA
Original source

The FDA has granted Swedish Match USA, Inc. permission to market 20 ZYN nicotine pouch products with specific modified risk claims. These claims state that using ZYN instead of cigarettes may lower the risk of several serious health conditions. This decision follows a thorough scientific review by the FDA to provide adult consumers with evidence-based information on tobacco product harms.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai